| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Onyia Jude is a Chief Scientific Officer at NEUROCRINE BIOSCIENCES INC. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $4.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2023 | NBIX Neurocrine Biosciences Inc | Chief Scientific Officer | Sell | 3,198 | $107.37 | $343,367.98 | -24.9% | +1.0% | +38.1% | |
| Feb 7, 2023 | NBIX Neurocrine Biosciences Inc | Chief Scientific Officer | Sell | 4,508 | $102.30 | $461,166.15 | -40.9% | -5.7% | +31.3% | |
| Jan 31, 2023 | NBIX Neurocrine Biosciences Inc | Chief Scientific Officer | Sell | 126 | $108.48 | $13,668.48 | -4.8% | -6.2% | +26.0% | |
| Nov 29, 2022 | NBIX Neurocrine Biosciences Inc | Chief Scientific Officer | Sell | 2,331 | $121.90 | $284,160.09 | -49.6% | -16.1% | -6.7% |